Trijardy XR 5 mg/1
empagliflozin, linagliptin, metformin hydrochloride · TABLET, EXTENDED RELEASE · Boehringer Ingelheim Pharmaceuticals, Inc.
Trijardy XR is a tablet, extended release containing empagliflozin, linagliptin, metformin hydrochloride at 5 mg/1, taken oral. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Trijardy XR
- Generic Name
- empagliflozin, linagliptin, metformin hydrochloride
- NDC Code (Product)
0597-0395- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Strength
- 5 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA212614
- Drug Class
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitor [EPC]
- Marketing Start
- 04/23/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Trijardy XR used for?
Trijardy XR contains empagliflozin, linagliptin, metformin hydrochloride. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is Trijardy XR a controlled substance?
Trijardy XR is not classified as a controlled substance by the DEA.
What is the generic name for Trijardy XR?
The generic name for Trijardy XR is empagliflozin, linagliptin, metformin hydrochloride. There are no other listed brand versions of empagliflozin, linagliptin, metformin hydrochloride.
What is the NDC code for Trijardy XR 5 mg/1?
The NDC (National Drug Code) for Trijardy XR 5 mg/1 is 0597-0395, listed by Boehringer Ingelheim Pharmaceuticals, Inc..
Other Trijardy XR Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)